The bill would bring dramatic changes to the Medicaid program, but it also has implications for drug prices, managed care ...

On Wednesday, U.S. Senators Catherine Cortez Masto (D-Nev.), Amy Klobuchar (D-Minn.), and Peter Welch (D- Vt.) introduced the ...

At least six organizations that claim to champion patient rights have deep financial and operational ties to Big Pharma and ...

The EO revives effort to link U.S. drug prices to those in peer countries, calling for voluntary industry action. Aggressive ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Tariffs on medications and raw ingredients impact global drug prices - hurting consumers and adding pressure to the healthcare system.